Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus Infection
The Journal of Infectious Diseases · 08.05.2024 · 229 (Supplement_3) · S362-S369
DOI: 10.1093/infdis/jiad177 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 22.09.2023. Verfasst von Gregory P Fricker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis C. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The current multiday diagnosis and treatment paradigm for hepatitis C virus (HCV) infection results in far fewer patients receiving treatment with direct-acting antiviral agents than those with diagnosed HCV infection. To achieve HCV elimination, a paradigm shift in access to HCV treatment is needed from multiday testing and treatment algorithms to same-day diagnosis and treatment. This shift will require new tools, such as point-of-care (POC) antigen tests or nucleic acid tests for HCV and hepatitis B virus (HBV) and nucleic acid tests for human immunodeficiency virus (HIV) that do not require venous blood. This shift will also require better use of existing resources, including expanded access to HCV treatment and available POC tests, novel monitoring approaches, and removal of barriers to approval. A same-day diagnosis and treatment paradigm will substantially contribute to HCV elimination by improving HCV treatment rates and expanding access to treatment in settings where patients have brief encounters with healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Infectious Diseases, Cherokee Nation Health Services, Tahlequah, Oklahoma, USA.
- Department of Medicine, Division of Infectious Diseases, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
- Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
- Department of Medicine, Division of Infectious Diseases and Geographic Medicine, University School of Medicine, Stanford, CaliforniaUSA.
ORCID-Profile: Gregory P Fricker
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Fricker, G. P., Ghany, M. G., Mera, J., Pinsky, B. A., Ward, J. W., & Chung, R. T. (2024). Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus Infection. The Journal of Infectious Diseases, 229(Supplement_3), S362-S369. https://doi.org/10.1093/infdis/jiad177
Vancouver
Fricker GP, Ghany MG, Mera J, Pinsky BA, Ward JW, Chung RT. Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus Infection. The Journal of Infectious Diseases. 2024;229(Supplement_3):S362-S369. doi:10.1093/infdis/jiad177
BibTeX
@article{Fricker2024,
author = {Fricker, Gregory P and Ghany, Marc G and Mera, Jorge and Pinsky, Benjamin A and Ward, John W and Chung, Raymond T},
title = {Tools Needed to Support Same-Day Diagnosis and Treatment of Current Hepatitis C Virus Infection},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {229},
number = {Supplement_3},
pages = {S362--S369},
doi = {10.1093/infdis/jiad177}
}
EUVIMED